Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
about
Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.Pharmacological Threat to Lungs: A Case Series and Literature Review.Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.A Case of Statin-Induced Interstitial Pneumonitis due to Rosuvastatin.Timolol-induced interstitial lung disease.Hypersensitivity Pneumonitis Caused by Cephalosporins With Identical R1 Side Chains.Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma.Acute respiratory failure secondary to mesalamine-induced interstitial pneumonitis.Inhibition of fibrosis and inflammation by triple therapy with pirfenidone, edaravone and erythropoietin in rabbits with drug-induced lung injury: comparison of CT imaging and pathological findings.Drug-induced Pneumonitis Following the Administration of TAS-102.Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse ReactionAntineoplastic therapy-induced pulmonary toxicity.Chlorambucil-induced acute interstitial pneumonitis.Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases.Association between infection and severe drug adverse reactions: an analysis using data from the Japanese Adverse Drug Event Report database.Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.Soluble thrombomodulin in bronchoalveolar lavage fluid is an independent predictor of severe drug-induced lung injury.Bevacizumab-induced chronic interstitial pneumonia during maintenance therapy in non-small cell lung cancer.A case of drug-induced interstitial pneumonitis caused by valproic Acid for the treatment of seizure disorders.A case of vildagliptin-induced interstitial pneumoniaVildagliptin-induced acute lung injury: a case report.Fatal rituximab-associated lung injury syndrome in a patient treated with rituximab for recurrence of post-transplant nephrotic syndrome.Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer.Acute respiratory distress syndrome; A rare complication caused by usage of ruxolitinib.Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.Development of interstitial pneumonia during treatment with eribulin: a case report.The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case-control study.Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.An untreatable dyspnoea: more defendants under investigation.Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma.In Silico Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods and Structural Alerts.Surfactant protein D is a useful biomarker for monitoring acute lung injury in rats.An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.
P2860
Q33410375-DDA3905D-3C38-446A-B4E8-65B5CF8B704BQ33629692-9D6045F9-4093-47B4-9662-FF144867CA96Q33787981-C7583D71-BF43-4A45-8CE9-F945E937E2B9Q35538449-36CC166E-0962-4A21-A5F2-430D8506ADE3Q35843845-3605F5C9-24E5-4FD9-99C7-2A47842BCF42Q35849416-02981BFB-FC16-4B36-9719-836E4BDFE6CCQ35872156-5121EA19-082F-409F-8668-D83D67A817D4Q36491549-00DCB740-44A4-4C67-AD2C-3280B2E067C1Q37143102-55B6C6AF-442C-4B37-9B31-E48454E8C4B5Q37289134-36994905-2683-4DEB-8D5A-05612F1AE244Q37383193-796D979D-C70F-4CC7-BCBC-DA0B915B231AQ37734343-C42608C8-04E9-43CC-9D2C-A27041E52169Q38132247-0BA97580-1C72-4114-ABAD-DE5B2CD1770CQ38202645-8645A539-783D-4A84-8C4B-266B09EE558EQ38382112-6229BE4F-53A8-4D4C-B6C6-1F3B48EF2844Q38613096-9D563D1F-D57E-454A-BD04-49C50C7B5C27Q38684504-80F65811-EA14-4267-BB2D-D2E74BA95062Q39099264-490B09E0-3E6F-4FBE-8513-F6F6F8B0302BQ39809681-2307E892-BF28-456C-A6F2-8FA929B91032Q40187257-F3159D1A-24EF-4113-A2FF-749B959080A0Q40475846-67391F7E-19C0-4D1C-88F8-F33AE425637EQ40577527-90B6DC39-F7C3-4C9E-AFF8-AE7C0400056BQ41269163-3BD8CAF4-21B6-480E-B14B-59C8277E3D96Q42079206-FF9EA548-B63C-45C9-B885-C42C0E86EFA2Q42362209-D6E5226B-5247-41A0-AFE4-7163431C187FQ42908395-06A2526B-FB4C-4493-9F87-1BFD7A0894E1Q47109996-420F2C7E-48FF-488A-8C2B-D28D0E6582ACQ47167193-9907B02C-9E62-44B9-BEDA-8F0D6AC2D0B2Q47949008-EA5084D0-6CCD-48B5-B03D-11902EC66F07Q47974675-3DBA1757-34B1-431E-940F-055201B75EAEQ50348815-5F03A8C6-FD81-4898-8689-91E1EB407F21Q50420418-A6499C33-C2AD-42F6-8AB1-3B6F4A43F12BQ51468547-AC736BEC-F605-453D-8E1B-E366F675317FQ52719665-8F618807-DD19-48A2-BE5B-22794D6FE89C
P2860
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
@en
type
label
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
@en
prefLabel
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
@en
P2860
P356
P1433
P1476
Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.
@en
P2093
Osamu Matsuno
P2860
P2888
P356
10.1186/1465-9921-13-39
P577
2012-05-31T00:00:00Z
P5875
P6179
1038780439